PD-1, gender, and autoimmunity

被引:106
作者
Dinesh, Ravi K. [1 ]
Hahn, Bevra H. [1 ]
Singh, Ram Pyare [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Rheumatol, Los Angeles, CA 90095 USA
关键词
PD-1; Gender; Sex hormones; Autoimmunity; Systemic lupus erythematosus; Immune system; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CD8(+) T-CELLS; PROGRAMMED DEATH-1 PD-1; ESTROGEN-TREATED MICE; RHEUMATOID-ARTHRITIS; DISEASE PROGRESSION; B7; FAMILY; REGULATORY POLYMORPHISM; CLINICAL-SIGNIFICANCE; B7-RELATED MOLECULE;
D O I
10.1016/j.autrev.2010.04.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Programmed death 1 (PD-1) and its ligands (PD-L1 and PD-L2) are responsible for inhibitory T cell signaling that helps mediate the mechanisms of tolerance and immune homeostasis. The PD-1:PD-L signaling pathway has been shown to play an important role in a variety of diseases, including autoimmune conditions, chronic infection, and cancer. Recently, investigators have explored the role of sex hormones in modulating the pathway in autoimmune conditions. Exploring the effects of sex hormones on the PD-1:PD-L pathway could shed light on the gender biased nature of many autoimmune conditions as well as aide in the development of therapeutics targeting the immune system. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:583 / 587
页数:5
相关论文
共 93 条
[1]
The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice [J].
Ansari, MJI ;
Salama, AD ;
Chitnis, T ;
Smith, RN ;
Yagita, H ;
Akiba, H ;
Yamazaki, T ;
Azuma, M ;
Iwai, H ;
Khoury, SJ ;
Auchincloss, H ;
Sayegh, MH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) :63-69
[2]
The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRL lpr/lpr mice [J].
Apelgren, LD ;
Bailey, DL ;
Fouts, RL ;
Short, L ;
Bryan, N ;
Evans, GF ;
Sandusky, GE ;
Zuckerman, SH ;
Glasebrook, A ;
Bumol, TF .
CELLULAR IMMUNOLOGY, 1996, 173 (01) :55-63
[3]
Baecher-Allan C, 2003, NOVART FDN SYMP, V252, P91
[4]
Baecher-Allan Clare, 2003, Novartis Found Symp, V252, P67
[5]
BAECHERALLAN C, 2003, NOVART FDN SYMP, V252, P106, DOI DOI 10.1002/0470871628.CH6
[6]
Restoring function in exhausted CD8 T cells during chronic viral infection [J].
Barber, DL ;
Wherry, EJ ;
Masopust, D ;
Zhu, BG ;
Allison, JP ;
Sharpe, AH ;
Freeman, GJ ;
Ahmed, R .
NATURE, 2006, 439 (7077) :682-687
[7]
PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells [J].
Blank, C ;
Brown, I ;
Peterson, AC ;
Spiotto, M ;
Iwai, Y ;
Honjo, T ;
Gajewski, TF .
CANCER RESEARCH, 2004, 64 (03) :1140-1145
[8]
Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-γ-dependent mechanism [J].
Blazar, BR ;
Carreno, BM ;
Panoskaltsis-Mortari, A ;
Carter, L ;
Iwai, Y ;
Yagita, H ;
Nishimura, H ;
Taylor, PA .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1272-1277
[9]
Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection [J].
Boettler, T ;
Panther, E ;
Bengsch, B ;
Nazarova, N ;
Spangenberg, HC ;
Blum, HE ;
Thimme, R .
JOURNAL OF VIROLOGY, 2006, 80 (07) :3532-3540
[10]
Blockade of programmed death-1 Ligands on dendritic cells enhances T cell activation and cytokine production [J].
Brown, JA ;
Dorfman, DM ;
Ma, FR ;
Sullivan, EL ;
Munoz, O ;
Wood, CR ;
Greenfield, EA ;
Freeman, GJ .
JOURNAL OF IMMUNOLOGY, 2003, 170 (03) :1257-1266